Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · IEX Real-Time Price · USD
0.880
-0.066 (-6.93%)
At close: Jul 2, 2024, 4:00 PM
0.920
+0.040 (4.55%)
After-hours: Jul 2, 2024, 7:21 PM EDT
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $121.08 million as of July 2, 2024. Its market cap has decreased by -69.62% in one year.
Market Cap
121.08M
Enterprise Value
-33.76M
1-Year Change
-69.62%
Ranking
Category
Stock Price
$0.88
Market Cap Chart
Since November 3, 2021, Compass Therapeutics's market cap has decreased from $219.00M to $121.08M, a decrease of -44.71%. That is a compound annual growth rate of -19.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 130.20M | -34.54% |
| Dec 29, 2023 | 198.90M | -68.66% |
| Dec 30, 2022 | 634.70M | 104.21% |
| Dec 31, 2021 | 310.80M | 41.92% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tevogen Bio Holdings | 125.34M |
| Cellectis | 124.75M |
| G1 Therapeutics | 124.17M |
| I-Mab | 122.85M |
| Harvard Bioscience | 122.04M |
| Regulus Therapeutics | 121.11M |
| Amylyx Pharmaceuticals | 120.37M |
| Telomir Pharmaceuticals | 119.33M |